RGC:NSD-Regencell Bioscience Holdings Ltd (USD)

COMMON STOCK | Other |

Last Closing

USD 5.39

Change

-0.16 (-2.80)%

Market Cap

USD 3.60B

Volume

0.05M

Analyst Target

USD 22.75
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Regal Entertainment Group, together with its subsidiaries, operates as a motion picture exhibitor in the United States. The company develops, acquires, and operates multi-screen theatres primarily in mid-sized metropolitan markets and suburban growth areas of larger metropolitan markets. It operates a theatre circuit under the brands of Regal Cinemas, United Artists, Edwards, Great Escape Theatres, and Hollywood Theaters. As of March 7, 2017, the company operated 7,267 screens in 561 theatres in 42 states along with Guam, Saipan, American Samoa, and the District of Columbia. Regal Entertainment Group was founded in 2002 and is based in Knoxville, Tennessee.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap
WOOF Pet Acquisition LLC

-0.08 (-1.76%)

USD 7.56B
JSM Navient Corporation SR NT 6% 1..

+0.07 (+0.34%)

USD 5.53B
BHFAL Brighthouse Financial Inc

-0.19 (-0.75%)

USD 5.18B
OB Outbrain Inc

-0.06 (-1.23%)

USD 1.71B
RILYG B. Riley Financial Inc. 5.00% ..

+0.22 (+1.91%)

USD 0.54B
RILYZ B. Riley Financial Inc. 5.25% ..

+0.24 (+2.82%)

USD 0.54B
NEWTZ Newtek Business Services Corp...

+0.05 (+0.20%)

USD 0.45B
NEWTI NewtekOne, Inc. 8.00% Fixed Ra..

-0.13 (-0.51%)

USD 0.43B
GAINN Gladstone Investment Corporati..

N/A

USD 0.39B
RELY Remitly Global Inc

N/A

USD 0.37B

ETFs Containing RGC

N/A

Market Performance

  Market Performance vs. Industry/Classification (Other) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -48.67% 12% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -48.67% 12% F 18% F
Trailing 12 Months  
Capital Gain -65.67% 8% B- 12% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -65.67% 8% B- 12% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -23.05% N/A N/A 15% F
Dividend Return -23.05% N/A N/A 15% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 38.40% N/A N/A 48% F
Risk Adjusted Return -60.02% N/A N/A 15% F
Market Capitalization 3.60B 83% B 86% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Negative Book Value

The company has negative book value.